I suspect the same, markets want to see actual revenue. A commitment for the $11m may see a bump up in SP but I don't think it will last and we will see the SP come down again.
Now, if they confirm the 50m+ orders(actual P.O.) then we will see a bump up imo.
I would like to see some big pharma move in to test the product, that is where the big money is going to come from long term imo.